BALCAO · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · SMALL CAP
Escalon Medical Corp. ESMC
15 fiscal years on record · USD · FY2024 reported
SEC FILINGS ONLY
Revenue · FY2024
$12.0M
▲ 0.5% vs FY2023
EPS · FY24
$0.00
Dividend / sh · FY24
—
Payout · FY24
—
ROE · FY24
5.7%
Net margin · FY24
0.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 12.0M
Revenue, FY2024 · full 15-year series below
Revenue
Net income
1 cents of every revenue dollar became profit this year.
Per share
USD 0.00
Diluted EPS, FY2024
EPS
The company pays no cash dividend.
Profitability
5.7%
Return on equity, FY2024
ROE
Operating margin1.1%
Net margin0.9%
Return on assets2.2%
Each USD of equity produced 6 cents of profit this year.
Returned to shareholders
—
returned in FY2024 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+5.1% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+4.0%
+5.1%
−0.9%
Net income
+80.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2024
Change, 5 years+0.0%
Change, 10 years−1.5%
The share count grew 0% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 5.0M
total assets, end of FY2024
Total assetsUSD 5.0M
EquityUSD 1.9M
CashUSD 545,835.00
Current ratio1.72×
Equity funds 38% of total assets.
History
15 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
0.0
−0.0
0.0
−0.0
0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
0.0
0.0
0.0
−0.0
Net income $B
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
EPS, diluted $
0.00
−0.02
0.03
0.00
−0.01
−0.09
−0.04
0.06
−0.10
−0.15
−0.07
−0.05
0.35
−0.79
−0.77
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
5.7
−6.7
26.8
1.2
−3.5
−35.4
−10.9
32.5
−47.0
−47.0
−16.8
−10.5
117.3
−174.0
−93.0
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
43 of 43
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed